1. Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1 n-3 DPA .
- Author
-
Tungen JE, Gerstmann L, Vik A, De Matteis R, Colas RA, Dalli J, Chiang N, Serhan CN, Kalesse M, and Hansen TV
- Subjects
- Animals, Anti-Inflammatory Agents metabolism, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents therapeutic use, Humans, Inflammation pathology, Inflammation prevention & control, Macrophages cytology, Macrophages drug effects, Macrophages metabolism, Neutrophils cytology, Neutrophils drug effects, Neutrophils metabolism, Quantum Theory, Receptors, G-Protein-Coupled agonists, Receptors, G-Protein-Coupled metabolism, Stereoisomerism, Anti-Inflammatory Agents chemical synthesis, Docosahexaenoic Acids chemistry, Fatty Acids, Unsaturated chemistry
- Abstract
New drugs that can resolve inflammation without immunosuppressive effects are at the medicinal chemistry frontier. Pro-resolving endogenously formed small molecules, that is, the resolvins, are excellent candidates displaying such bioactions. The first total synthesis of the specialized pro-resolving mediator RvD1
n-3 DPA has been achieved using the underutilized sp3 -sp3 Negishi cross coupling reaction and an alkyne hydrosilylation-protodesilylation protocol. Biological evaluations revealed that this novel mediator displays low nanomolar pro-resolving properties and potently activates the human DRV1/GPR32 receptor. As such, this endogenous natural product is a lead compound for the development of novel immunoresolvents., (© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2019
- Full Text
- View/download PDF